Home » SynBioBeta Live » SynBioBeta Live: COVID-19 antibodies roundtable

SynBioBeta Live: COVID-19 antibodies roundtable

Brought to you by:

Twist Bioscience

Whether it’s testing, treatment, or vaccine development, antibodies are at the center of the research community’s race to put coronavirus behind us. Join our distinguished panel in conversation about the latest antibody developments in the fight against COVID-19. We’ll discuss breakthroughs, bottlenecks, tech and regulatory hurdles, and the challenges to scale-up. Guests include:


Joe DeRisi, Co-President of Chan Zuckerberg Biohub
Casey Lippmeier
Casey Lippmeier, VP of Research & Development at Conagen

Aaron Sato, CSO of Biopharma at Twist Bioscience
James Crowe
James Crowe, Director of the Vanderbilt Vaccine Center

Lan Tang, U.S. Business Development Executive at GenScript

Eric Hobbs, CEO of Berkeley Lights

Karl Handelsman, Founder of Codon Capital

Neekta Hamidi, Associate at Schmidt Futures

Shawdee Eshghi, Mammalian Cell Engineering at Ginkgo Bioworks

Sara Holoubek, CEO of Luminary Labs

Joe Fernandez, CEO of Active Motif

Sean McClain, CEO of AbSci
Jake Glanville
Jake Glanville, CEO of Distributed Bio

David Mace, CEO of SwiftScale Biologics

Recorded Friday, April 17 at 8 am Pacific

14
Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks